Zhou et al. [109] used the orthogonal dual molecularly imprinted polymer-based plasmonic immune sandwich assay (od-MIP-PISA) for the detection of CEA, commonly used as a marker for colon cancer. Here, CEACAM5 is linked to malignant colon neoplasm.